Edwards Lifesciences Corporation (EW): Price and Financial Metrics


Edwards Lifesciences Corporation (EW): $112.16

0.59 (+0.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EW POWR Grades


  • Quality is the dimension where EW ranks best; there it ranks ahead of 92.34% of US stocks.
  • The strongest trend for EW is in Stability, which has been heading up over the past 51 weeks.
  • EW ranks lowest in Momentum; there it ranks in the 31st percentile.

EW Stock Summary

  • With a market capitalization of $69,544,687,444, Edwards Lifesciences Corp has a greater market value than 96.22% of US stocks.
  • The price/operating cash flow metric for Edwards Lifesciences Corp is higher than 90.24% of stocks in our set with a positive cash flow.
  • EW's price/sales ratio is 14.12; that's higher than the P/S ratio of 87.03% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Edwards Lifesciences Corp are ATVI, NTES, SPOT, HMC, and KEYS.
  • Visit EW's SEC page to see the company's official filings. To visit the company's web site, go to www.edwards.com.

EW Valuation Summary

  • In comparison to the median Healthcare stock, EW's price/earnings ratio is 36.71% higher, now standing at 49.9.
  • Over the past 243 months, EW's price/earnings ratio has gone up 116.6.
  • Over the past 243 months, EW's EV/EBIT ratio has gone down 314.3.

Below are key valuation metrics over time for EW.

Stock Date P/S P/B P/E EV/EBIT
EW 2021-08-31 14.8 14.2 49.9 43.4
EW 2021-08-30 14.9 14.3 50.3 43.7
EW 2021-08-27 14.7 14.1 49.6 43.1
EW 2021-08-26 14.8 14.2 49.9 43.3
EW 2021-08-25 14.8 14.2 49.9 43.3
EW 2021-08-24 14.9 14.3 50.3 43.7

EW Growth Metrics

  • The 5 year revenue growth rate now stands at 79.8%.
  • Its 4 year revenue growth rate is now at 72.4%.
  • Its year over year price growth rate is now at 36.21%.
EW's revenue has moved up $1,692,800,000 over the prior 49 months.

The table below shows EW's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 4,925.2 1,442.7 1,462.4
2021-03-31 4,474.2 1,147.8 851
2020-12-31 4,386.3 1,054.3 823.4
2020-09-30 4,368.7 1,053.7 794.1
2020-06-30 4,321.8 1,274.9 743.6
2020-03-31 4,483.7 1,384.9 1,107.8

EW's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EW has a Quality Grade of B, ranking ahead of 92.34% of graded US stocks.
  • EW's asset turnover comes in at 0.681 -- ranking 54th of 185 Medical Equipment stocks.
  • ATRS, IVC, and SRDX are the stocks whose asset turnover ratios are most correlated with EW.

The table below shows EW's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.681 0.755 0.381
2021-03-31 0.647 0.752 0.229
2020-12-31 0.661 0.754 0.231
2020-09-30 0.678 0.755 0.235
2020-06-30 0.693 0.750 0.233
2020-03-31 0.744 0.744 0.370

EW Price Target

For more insight on analysts targets of EW, see our EW price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $119.36 Average Broker Recommendation 1.62 (Moderate Buy)

EW Stock Price Chart Interactive Chart >

Price chart for EW

EW Price/Volume Stats

Current price $112.16 52-week high $123.27
Prev. close $111.57 52-week low $70.92
Day low $111.54 Volume 1,666,900
Day high $112.49 Avg. volume 2,459,815
50-day MA $115.90 Dividend yield N/A
200-day MA $98.49 Market Cap 69.91B

Edwards Lifesciences Corporation (EW) Company Bio


Edwards Lifesciences provides products and technologies to treat structural heart disease and critically ill patients worldwide. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The company was founded in 1999 and is based in Irvine, California.


EW Latest News Stream


Event/Time News Detail
Loading, please wait...

EW Latest Social Stream


Loading social stream, please wait...

View Full EW Social Stream

Latest EW News From Around the Web

Below are the latest news stories about Edwards Lifesciences Corp that investors may wish to consider to help them evaluate EW as an investment opportunity.

Top Analyst Reports for Edwards Lifesciences, DexCom & Twitter

Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).

Yahoo | October 15, 2021

Is Edwards Lifesciences Corp. (EW) A Great Investment Pick?

Wedgewood Partners, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly portfolio net return of +2.75% was recorded by the fund for the third quarter of 2021, outperforming the S&P 500 Index that delivered a +0.58% return for the same period, and the […]

Yahoo | October 15, 2021

EW December 17th Options Begin Trading

Investors in Edwards Lifesciences Corp (Symbol: EW) saw new options become available today, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EW options chain for the new December 17th contracts and identified one pu

iShook Finance | October 14, 2021

Edwards Lifesciences (EW) to Post Q3 Earnings: What''s in Store?

Edwards Lifesciences Corporation EW is expected to report third-quarter 2021 results on Oct 20, after market close.

iShook Finance | October 14, 2021

Boston Scientific (BSX) Inks New Deal to Buy Baylis Medical

The Baylis Medical buyout is expected to expand Boston Scientific's (BSX) electrophysiology and structural heart product offerings.

Yahoo | October 14, 2021

Read More 'EW' Stories Here

EW Price Returns

1-mo -7.07%
3-mo 4.90%
6-mo 26.65%
1-year 31.44%
3-year 126.39%
5-year 191.20%
YTD 22.94%
2020 17.32%
2019 52.31%
2018 35.90%
2017 20.29%
2016 18.64%

Continue Researching EW

Here are a few links from around the web to help you further your research on Edwards Lifesciences Corp's stock as an investment opportunity:

Edwards Lifesciences Corp (EW) Stock Price | Nasdaq
Edwards Lifesciences Corp (EW) Stock Quote, History and News - Yahoo Finance
Edwards Lifesciences Corp (EW) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.949 seconds.